+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
PD-1 & PD-L1 Inhibitors Market by Product Type, Indication, End User, Distribution Channel, Route Of Administration, Company - Global Forecast to 2030- Product Image
PD-1 & PD-L1 Inhibitors Market by Product Type, Indication, End User, Distribution Channel, Route Of Administration, Company - Global Forecast to 2030- Product Image
Sale

PD-1 & PD-L1 Inhibitors Market by Product Type, Indication, End User, Distribution Channel, Route Of Administration, Company - Global Forecast to 2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674438
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The PD-1 & PD-L1 Inhibitors Market is rapidly reshaping the landscape of immuno-oncology, empowering healthcare systems with innovative therapies that address unmet clinical needs. With an evolving array of targeted agents, this sector is driving significant change in treatment standards and industry strategies for cancer care.

Market Snapshot: PD-1 & PD-L1 Inhibitors Market Growth and Opportunities

Driven by expanded indications, combination protocols, and breakthroughs in immune checkpoint inhibition, the PD-1 & PD-L1 Inhibitors Market is on a trajectory of substantial growth. The sector is characterized by strong clinical momentum, evolving regulatory frameworks, and the increasing integration of advanced diagnostics to guide therapy selection. Leading pharmaceutical companies and emerging biotech firms alike are uplifting their research and commercialization to capture growing demand across key cancer types. Pipeline innovations and adaptive regulatory responses are reshaping competitive dynamics, while strategic use of precision medicine is deepening market penetration and shaping global adoption.

Scope & Segmentation Analysis

This comprehensive report systematically examines all critical facets of the PD-1 & PD-L1 Inhibitors Market and its ecosystem. The analysis covers:

  • Product Type: PD-1 inhibitors (Cemiplimab, Nivolumab, Pembrolizumab) and PD-L1 inhibitors (Atezolizumab, Avelumab, Durvalumab)
  • Indication: Bladder cancer, head and neck cancer, lung cancer, melanoma, renal cell carcinoma
  • End User: Hospitals, research institutes, specialty clinics
  • Distribution Channel: Hospital pharmacy, online pharmacy, retail pharmacy
  • Route of Administration: Intravenous, subcutaneous
  • Company: AstraZeneca, Bristol-Myers Squibb, Merck & Co., Roche, Merck KGaA, Pfizer, BeiGene, Innovent Biologics, CStone Pharmaceuticals, Shanghai Junshi Biosciences
  • Region: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, and several others), and Asia-Pacific (notably China, India, Japan, Australia, South Korea, Southeast Asian countries)

Advanced technologies in patient selection, such as tumor mutational burden panels and PD-L1 expression panels, are also included in the analysis. The report evaluates both established and emerging players, mapping the impact of innovative delivery formulations and real-world evidence initiatives throughout the market.

Key Takeaways for Industry Leaders

  • Checkpoint inhibition therapies are now integrated in multi-modal cancer regimens, supporting both early-stage and advanced disease management.
  • Strategic collaborations, particularly between leading pharmaceutical incumbents and biotech innovators, are fostering the development of next-generation antibodies and combination treatments.
  • Precision diagnostics are underpinning tailored treatment pathways, increasing clinical value and optimizing patient outcomes across diverse care settings.
  • Expansion into subcutaneous delivery options is accelerating, driven by patient-centric care models and the need for healthcare provider efficiency in both hospitals and specialty clinics.
  • Regional market dynamics necessitate tailored access and pricing strategies due to variations in reimbursement, healthcare infrastructure, and regulatory standards.
  • Smaller and emerging firms are leveraging agile trial designs and focused R&D to compete for entry in less crowded but strategically important cancer subtypes.

Tariff Impact: Navigating Policy Risks

The 2025 US tariff adjustments are set to alter pricing structures and supply chains by introducing new duties on imported agents and ingredients, compelling manufacturers and payers to adjust their cost-management and sourcing strategies. Effective scenario planning and partnership with domestic producers will be crucial for mitigating volatility, ensuring continuous market access, and upholding commitments to patient care.

Methodology & Data Sources

Market insights are derived using an integrated approach, combining qualitative expert interviews with key stakeholders, in-depth reviews of clinical and regulatory databases, and comprehensive analysis of company pipelines and transaction records. Data triangulation ensures reliability and robust coverage across therapeutic, technological, and regional dimensions.

Why This Report Matters

  • Equips decision-makers to anticipate shifts in the competitive immuno-oncology landscape and align strategic planning with evolving therapeutic standards.
  • Enables effective allocation of resources by illuminating the impact of regulatory, tariff, and market-access developments across regions and cancer types.
  • Supports portfolio development and investment by providing curated insights into innovation, distribution evolution, and partnership opportunities.

Conclusion

The future of the PD-1 & PD-L1 Inhibitors Market will be defined by innovation, agile strategy, and adaptation to evolving regional and policy environments. This report offers the actionable intelligence needed to navigate complexity and drive value for patients and stakeholders in oncology.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. PD-1 & PD-L1 Inhibitors Market, by Product Type
8.1. Introduction
8.2. PD-1 Inhibitor
8.2.1. Cemiplimab
8.2.2. Nivolumab
8.2.3. Pembrolizumab
8.3. PD-L1 Inhibitor
8.3.1. Atezolizumab
8.3.2. Avelumab
8.3.3. Durvalumab
9. PD-1 & PD-L1 Inhibitors Market, by Indication
9.1. Introduction
9.2. Bladder Cancer
9.3. Head And Neck Cancer
9.4. Lung Cancer
9.5. Melanoma
9.6. Renal Cell Carcinoma
10. PD-1 & PD-L1 Inhibitors Market, by End User
10.1. Introduction
10.2. Hospitals
10.3. Research Institutes
10.4. Specialty Clinics
11. PD-1 & PD-L1 Inhibitors Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. PD-1 & PD-L1 Inhibitors Market, by Route Of Administration
12.1. Introduction
12.2. Intravenous
12.3. Subcutaneous
13. PD-1 & PD-L1 Inhibitors Market, by Company
13.1. Introduction
13.2. AstraZeneca
13.3. Bristol-Myers Squibb
13.4. Merck & Co.
13.5. Roche
14. Americas PD-1 & PD-L1 Inhibitors Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa PD-1 & PD-L1 Inhibitors Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific PD-1 & PD-L1 Inhibitors Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Merck & Co., Inc.
17.3.2. Bristol-Myers Squibb Company
17.3.3. F. Hoffmann-La Roche Ltd
17.3.4. AstraZeneca PLC
17.3.5. Merck KGaA
17.3.6. Pfizer Inc.
17.3.7. BeiGene, Ltd.
17.3.8. Innovent Biologics, Inc.
17.3.9. CStone Pharmaceuticals
17.3.10. Shanghai Junshi Biosciences Co., Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. PD-1 & PD-L1 INHIBITORS MARKET MULTI-CURRENCY
FIGURE 2. PD-1 & PD-L1 INHIBITORS MARKET MULTI-LANGUAGE
FIGURE 3. PD-1 & PD-L1 INHIBITORS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COMPANY, 2024 VS 2030 (%)
FIGURE 18. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COMPANY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. PD-1 & PD-L1 INHIBITORS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. PD-1 & PD-L1 INHIBITORS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. PD-1 & PD-L1 INHIBITORS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-1 INHIBITOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY CEMIPLIMAB, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY NIVOLUMAB, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PEMBROLIZUMAB, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-L1 INHIBITOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ATEZOLIZUMAB, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY AVELUMAB, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DURVALUMAB, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-L1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY BLADDER CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY HEAD AND NECK CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY MELANOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY RENAL CELL CARCINOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ASTRAZENECA, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY BRISTOL-MYERS SQUIBB, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY MERCK & CO., BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROCHE, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-L1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-L1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 57. CANADA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 58. CANADA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 59. CANADA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-L1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 60. CANADA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 61. CANADA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. CANADA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 63. CANADA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 64. CANADA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 65. MEXICO PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 66. MEXICO PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 67. MEXICO PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-L1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 68. MEXICO PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 69. MEXICO PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. MEXICO PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. MEXICO PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 72. MEXICO PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-L1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-L1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-L1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-L1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 102. UNITED KINGDOM PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. UNITED KINGDOM PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 106. GERMANY PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 107. GERMANY PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 108. GERMANY PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-L1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 109. GERMANY PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 110. GERMANY PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. GERMANY PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. GERMANY PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 113. GERMANY PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 114. FRANCE PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 115. FRANCE PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 116. FRANCE PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-L1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 117. FRANCE PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 118. FRANCE PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. FRANCE PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. FRANCE PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 121. FRANCE PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-L1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. RUSSIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. RUSSIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 129. RUSSIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 130. ITALY PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 131. ITALY PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 132. ITALY PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-L1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 133. ITALY PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 134. ITALY PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. ITALY PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. ITALY PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 137. ITALY PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 138. SPAIN PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 139. SPAIN PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 140. SPAIN PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-L1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 141. SPAIN PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 142. SPAIN PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. SPAIN PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. SPAIN PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 145. SPAIN PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-L1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 153. UNITED ARAB EMIRATES PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-L1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-L1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 170. DENMARK PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 171. DENMARK PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 172. DENMARK PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-L1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 173. DENMARK PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 174. DENMARK PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. DENMARK PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 176. DENMARK PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 177. DENMARK PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 178. NETHERLANDS PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-L1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 181. NETHERLANDS PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 182. NETHERLANDS PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. NETHERLANDS PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 184. NETHERLANDS PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 185. NETHERLANDS PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 186. QATAR PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 187. QATAR PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 188. QATAR PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-L1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 189. QATAR PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 190. QATAR PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. QATAR PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. QATAR PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 193. QATAR PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 194. FINLAND PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 195. FINLAND PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 196. FINLAND PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-L1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 197. FINLAND PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 198. FINLAND PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. FINLAND PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 200. FINLAND PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 201. FINLAND PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 202. SWEDEN PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-L1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 205. SWEDEN PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 206. SWEDEN PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-L1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. NIGERIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 216. NIGERIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 217. NIGERIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 218. EGYPT PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 219. EGYPT PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 220. EGYPT PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-L1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 221. EGYPT PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 222. EGYPT PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. EGYPT PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 224. EGYPT PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 225. EGYPT PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 226. TURKEY PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 227. TURKEY PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 228. TURKEY PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-L1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 229. TURKEY PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 230. TURKEY PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 231. TURKEY PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 232. TURKEY PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 233. TURKEY PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 234. ISRAEL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-L1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 237. ISRAEL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 238. ISRAEL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. ISRAEL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 240. ISRAEL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 241. ISRAEL PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 242. NORWAY PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 243. NORWAY PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 244. NORWAY PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-L1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 245. NORWAY PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 246. NORWAY PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 247. NORWAY PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 248. NORWAY PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 249. NORWAY PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 250. POLAND PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 251. POLAND PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 252. POLAND PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-L1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 253. POLAND PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 254. POLAND PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. POLAND PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 256. POLAND PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 257. POLAND PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-L1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 265. SWITZERLAND PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-L1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 272. ASIA-PACIFIC PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 274. ASIA-PACIFIC PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 275. CHINA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 276. CHINA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 277. CHINA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-L1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 278. CHINA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 279. CHINA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. CHINA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 281. CHINA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 282. CHINA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 283. INDIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 284. INDIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 285. INDIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-L1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 286. INDIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 287. INDIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 288. INDIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 289. INDIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 290. INDIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 291. JAPAN PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 292. JAPAN PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 293. JAPAN PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-L1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 294. JAPAN PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 295. JAPAN PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 296. JAPAN PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 297. JAPAN PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 298. JAPAN PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 299. AUSTRALIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-L1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 302. AUSTRALIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 303. AUSTRALIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 304. AUSTRALIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 305. AUSTRALIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 306. AUSTRALIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 307. SOUTH KOREA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-L1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 310. SOUTH KOREA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 311. SOUTH KOREA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 312. SOUTH KOREA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 313. SOUTH KOREA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 314. SOUTH KOREA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 315. INDONESIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 316. INDONESIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 317. INDONESIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-L1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 318. INDONESIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 319. INDONESIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 320. INDONESIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 321. INDONESIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 322. INDONESIA PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 323. THAILAND PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 324. THAILAND PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 325. THAILAND PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY PD-L1 INHIBITOR, 2018-2030 (USD MILLION)
TABLE 326. THAILAND PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 327. THAILAND PD-1 & PD-L1 INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 328. THAILAND PD-1 & PD-L1 INHIBITORS MARKE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this PD-1 & PD-L1 Inhibitors market report include:
  • Merck & Co., Inc.
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche Ltd
  • AstraZeneca PLC
  • Merck KGaA
  • Pfizer Inc.
  • BeiGene, Ltd.
  • Innovent Biologics, Inc.
  • CStone Pharmaceuticals
  • Shanghai Junshi Biosciences Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages189
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 53.91 Billion
Forecasted Market Value ( USD ) by 2030 $ 137.93 Billion
Compound Annual Growth Rate20.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

PD-1 and PD-L1 Inhibitors Market Report and Forecast 2025-2034 - Product Image

PD-1 and PD-L1 Inhibitors Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
PD-1 And PD-L1 Inhibitors - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

PD-1 And PD-L1 Inhibitors - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 160 Pages
  • Global
From
PD-1 and PD-L1 Inhibitors - Global Strategic Business Report - Product Image

PD-1 and PD-L1 Inhibitors - Global Strategic Business Report

  • Report
  • 376 Pages
  • Global
From
PD-1 And PD-L1 Inhibitors - Pipeline Insight, 2025 - Product Image

PD-1 And PD-L1 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • 200 Pages
  • Global
From
PD-1 and PD-L1 Inhibitors - Competitive landscape, 2025 - Product Image

PD-1 and PD-L1 Inhibitors - Competitive landscape, 2025

  • Report
  • 400 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.